Trial Design, Treatment Options Spotlighted in Xylazine Conference
Longer observation periods following treatment and safety considerations for chronic and frequent users are among the many research issues about xylazine-laced fentanyl that need addressing, Rachel Wightman, MD, said at a meeting on mitigating risks from human xylazine exposure sponsored by the Reagan-Udall Foundation. “I take care of patients that are using fentanyl 10 plus […]